Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia.

Scientific reports

Lazzaroni F, Giacco LD, Biasci D, Turrini M, Prosperi L, Brusamolino R, Cairoli R, Beghini A.
PMID: 28443613
Sci Rep. 2017 Apr 26;7:46788. doi: 10.1038/srep46788.

No abstract available.

Cite
Lazzaroni F, Giacco LD, Biasci D, et al. Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia. Sci Rep. 2017;7:46788doi: 10.1038/srep46788.
Lazzaroni, F., Giacco, L. D., Biasci, D., Turrini, M., Prosperi, L., Brusamolino, R., Cairoli, R., & Beghini, A. (2017). Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia. Scientific reports, 746788. https://doi.org/10.1038/srep46788
Lazzaroni, Francesca, et al. "Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia." Scientific reports vol. 7 (2017): 46788. doi: https://doi.org/10.1038/srep46788
Lazzaroni F, Giacco LD, Biasci D, Turrini M, Prosperi L, Brusamolino R, Cairoli R, Beghini A. Corrigendum: Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia. Sci Rep. 2017 Apr 26;7:46788. doi: 10.1038/srep46788. PMID: 28443613; PMCID: PMC5405405.
Copy Download .nbib Format: NLM
The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy.

Mediterranean journal of hematology and infectious diseases

Brusamolino E, Gotti M, Fiaccadori V.
PMID: 22708037
Mediterr J Hematol Infect Dis. 2012;4(1):e2012022. doi: 10.4084/MJHID.2012.022. Epub 2012 Apr 06.

Patients with Hodgkin lymphoma treated with DNA-breaking alkylating agents such as mechlorethamine and procarbazine in the MOPP regimen and with topoisomerase II inhibitors, such as etoposide did show a long-term risk of developing therapy-related myelodysplasia and acute myelogenous leukaemia...

Cite
Brusamolino E, Gotti M, Fiaccadori V. The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy. Mediterr J Hematol Infect Dis. 2012;4(1):e2012022doi: 10.4084/MJHID.2012.022.
Brusamolino, E., Gotti, M., & Fiaccadori, V. (2012). The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy. Mediterranean journal of hematology and infectious diseases, 4(1), e2012022. https://doi.org/10.4084/MJHID.2012.022
Brusamolino, Ercole, et al. "The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy." Mediterranean journal of hematology and infectious diseases vol. 4,1 (2012): e2012022. doi: https://doi.org/10.4084/MJHID.2012.022
Brusamolino E, Gotti M, Fiaccadori V. The Risk of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia in Hodgkin Lymphoma has Substantially Decreased in the ABVD Era Abolishing Mechlorethamine and Procarbazine and Limiting Volumes and Doses of Radiotherapy. Mediterr J Hematol Infect Dis. 2012;4(1):e2012022. doi: 10.4084/MJHID.2012.022. Epub 2012 Apr 06. PMID: 22708037; PMCID: PMC3375741.
Copy Download .nbib Format: NLM
Primary hemangiopericytoma of bone - a case-report and literature-review.

International journal of oncology

Spagnolo R, Torelli L, Brusamolino R, Bono A, Rossi N, Zurrida S.
PMID: 21573598
Int J Oncol. 1993 Apr;2(4):601-5. doi: 10.3892/ijo.2.4.601.

Clinical, radiological and histological aspects of a case of primary bone haemangiopericytoma, treated by wide surgical resection and pre- and postoperative radiotherapy, are described. The patient was disease-free 20 months from the operation. From a literature review of 52...

Cite
Spagnolo R, Torelli L, Brusamolino R, et al. Primary hemangiopericytoma of bone - a case-report and literature-review. Int J Oncol. 1993;2(4):601-5doi: 10.3892/ijo.2.4.601.
Spagnolo, R., Torelli, L., Brusamolino, R., Bono, A., Rossi, N., & Zurrida, S. (1993). Primary hemangiopericytoma of bone - a case-report and literature-review. International journal of oncology, 2(4), 601-5. https://doi.org/10.3892/ijo.2.4.601
Spagnolo, R, et al. "Primary hemangiopericytoma of bone - a case-report and literature-review." International journal of oncology vol. 2,4 (1993): 601-5. doi: https://doi.org/10.3892/ijo.2.4.601
Spagnolo R, Torelli L, Brusamolino R, Bono A, Rossi N, Zurrida S. Primary hemangiopericytoma of bone - a case-report and literature-review. Int J Oncol. 1993 Apr;2(4):601-5. doi: 10.3892/ijo.2.4.601. PMID: 21573598.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries